ATE267611T1 - MENSCHLICHES ßMINOR VAULTß PROTEIN P193 - Google Patents

MENSCHLICHES ßMINOR VAULTß PROTEIN P193

Info

Publication number
ATE267611T1
ATE267611T1 AT98926210T AT98926210T ATE267611T1 AT E267611 T1 ATE267611 T1 AT E267611T1 AT 98926210 T AT98926210 T AT 98926210T AT 98926210 T AT98926210 T AT 98926210T AT E267611 T1 ATE267611 T1 AT E267611T1
Authority
AT
Austria
Prior art keywords
protein
ßminor
vaultß
human
vault protein
Prior art date
Application number
AT98926210T
Other languages
English (en)
Inventor
Leonard H Rome
Valerie A Kickhoefer
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE267611T1 publication Critical patent/ATE267611T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
AT98926210T 1998-06-03 1998-06-03 MENSCHLICHES ßMINOR VAULTß PROTEIN P193 ATE267611T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/011348 WO1999062547A1 (en) 1998-06-03 1998-06-03 HUMAN MINOR VAULT PROTEIN p193

Publications (1)

Publication Number Publication Date
ATE267611T1 true ATE267611T1 (de) 2004-06-15

Family

ID=22267215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98926210T ATE267611T1 (de) 1998-06-03 1998-06-03 MENSCHLICHES ßMINOR VAULTß PROTEIN P193

Country Status (7)

Country Link
EP (1) EP1083927B1 (de)
JP (1) JP2002516675A (de)
AT (1) ATE267611T1 (de)
AU (1) AU762371B2 (de)
CA (1) CA2330833A1 (de)
DE (1) DE69824206D1 (de)
WO (1) WO1999062547A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003232200A1 (en) * 2002-04-08 2003-10-20 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases
US8124109B2 (en) 2008-05-15 2012-02-28 The Regents Of The University Of California Vault compositions for immunization against chlamydia genital infection
AU2010313112B2 (en) 2009-11-02 2014-06-26 The Regents Of The University Of California Vault complexes for cytokine delivery
US8551781B2 (en) 2009-11-19 2013-10-08 The Regents Of The University Of California Vault complexes for facilitating biomolecule delivery
EP2921555B1 (de) * 2012-11-19 2019-01-02 Japan Science And Technology Agency Künstliche biopartikel und herstellungsverfahren dafür
CN112724253B (zh) * 2021-03-09 2022-04-05 生工生物工程(上海)股份有限公司 抗人穹窿体蛋白的抗体及其应用

Also Published As

Publication number Publication date
DE69824206D1 (de) 2004-07-01
AU7810398A (en) 1999-12-20
EP1083927A4 (de) 2002-01-02
EP1083927B1 (de) 2004-05-26
WO1999062547A1 (en) 1999-12-09
JP2002516675A (ja) 2002-06-11
EP1083927A1 (de) 2001-03-21
AU762371B2 (en) 2003-06-26
CA2330833A1 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
ATE358176T1 (de) Menschliche dnase
DE68924026D1 (de) Biosensor und dessen herstellung.
BR9506820A (pt) Derivados de 4-amino de ácido micofenólico
CA2301032A1 (en) A method of preventing or treating estrogen-dependent diseases and disorders
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
EP0292554A4 (de) Feuchtigkeitsbeständiges hautbehandlungsmittel.
IS5852A (is) Lyfjamiðlar til meðhöndlunar á parkinsonsveiki ADHD og smákirtilsæxlum
IS5056A (is) Ný meðhöndlun á liðbólgu
ATE267611T1 (de) MENSCHLICHES ßMINOR VAULTß PROTEIN P193
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
FR2716375B3 (fr) Injecteur médical.
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
DE60239670D1 (de) Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
PT1056458E (pt) Tratamento de dor cronica
EA200200319A1 (ru) Белок iren, его получение и использование
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
IL143279A0 (en) Novel therapeutic application of low molecular weight heparin
RU95114858A (ru) Новый пептидный фрагмент, обладающий биологической активностью инсулина
KR970023499U (ko) 생물학적 순산소 개방형 폐수 처리장치
FR2713479B1 (fr) Bassin médical.
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties